iRadimed (IRMD)
(Real Time Quote from BATS)
$72.18 USD
+0.72 (1.01%)
Updated Sep 17, 2025 09:46 AM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IRMD 72.18 +0.72(1.01%)
Will IRMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRMD
Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why
iRadimed (IRMD) Q2 Earnings and Revenues Surpass Estimates
IRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Integer (ITGR) Q2 Earnings Lag Estimates
New Strong Sell Stocks for June 12th
IRadimed (IRMD) Lags Q1 Earnings Estimates
Other News for IRMD
1,2,3 Pullback Bullish appears for IRMD after 0.21% move
20 Day Moving Average Resistance appears for IRMD after 0.48% move
IRMD forms Slingshot Bullish on September 12
IRMD makes New 52 Week Closing High on September 11
20 Day Moving Average Support appears for IRMD after 0.51% move